A
Arcadia Biosciences
Develops agricultural economic products to improve crops
About Arcadia Biosciences
Arcadia Biosciences operates in the agricultural biotechnology sector, focusing on developing innovative solutions that enhance crop yields, nutritional value, and environmental sustainability. The company serves farmers and food manufacturers by providing advanced agricultural products and technologies. Arcadia's business model revolves around creating value-added products such as GoodWheat and GoodHemp, which offer unique health benefits and improved plant qualities. The company generates revenue through the sale of these specialized ingredients and technologies, as well as through partnerships and collaborations with major food manufacturers and processors. Arcadia's market includes the global agricultural sector, with a particular emphasis on addressing the challenges posed by environmental and economic factors. By leveraging its proprietary technologies, Arcadia aims to maximize productivity and reduce the environmental impact of commercial farming.
Source: Dealroom company dataAt a glance
- Founded
- 2002
- Headquarters
- Davis, United States
- Listing
- IPO 2015
- Sector
- Food
Latest news
Press, funding announcements and product moves mentioning Arcadia Biosciences.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US National Science Foundation
Series B and later4 investors entered at this stage
- CCCMEA Capital
Saints Capital
Mandala Capital
Silicon Valley Bank
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Arcadia Biosciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arcadia Biosciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.